The relationship between clinical improvement after percutaneous transluminal angioplasty (PTA) and hemodynamic condition in vertebrobasilar insufficiency was evaluated in 43 patients between 45 and 86 years of age with clinically symptomatic atherosclerotic stenotic lesions in the posterior circula tion. The 43 patients had a total of 51 stenotic lesions, including 17 in the first segment of the ver tebral artery, 32 in the fourth segment of the vertebral artery, and two in the basilar artery. An giography was performed and cerebral perfusion was measured with technetium-99m-hexamethyl propyleneamine oxime single photon emission computed tomography before and after administration of 10 mg/kg acetazolamide prior to and more than 7 months after PTA. Mean stenosis was 81.3 &plusmn; 7.4% before PTA, but only 41.5 &plusmn; 17.4% at follow-up. Eighteen of the 24 patients with improved neurological condition after PTA had subnormal (&lt;mean -2 SDs) cerebral perfusion before PTA. Twenty of these 24 patients had subnormal vasodilatory response to administration of acetazolamide before PTA. Clini cal improvement following PTA was noted in only one of the 12 patients with a single stenotic lesion of the first segment, but in 23 of the 31 patients with intracranial stenotic or multiple stenotic lesions. PTA in the posterior circulation is indicated for patients with atherosclerotic stenotic intracranial le sion or multiple stenotic lesions who have subnormal cerebral perfusion and low vasodilatory response to administration of acetazolamide.
Introduction
Percutaneous transluminal angioplasty (PTA) is a widely used therapeutic modality for the treatment of coronary artery disease. PTA has been used for the treatment of cerebrovascular disease, but is not widely accepted because of the potential for distal embolization by atherosclerotic debris and inadver tent occlusion of perforating branches originating from the first segment of the middle cerebral artery or basilar artery when plaque is crushed. In contrast to the coronary and systemic arteries, occlusion of small and single perforators in the brain can prove devastating.3,',10,12,13,18,23,30,33-35,38) Small perforating branches do not have a collateral blood supply, and infarction will result in serious neurological deficits. the left cerebral hemisphere as measured by techneti um-99m-hexamethyl-propyleneamine oxime (99mTc HMPAO) single photon emission computed tomography (SPECT).231 Recently, PTA was used to treat atherosclerotic disease of the vertebral and basi lar arteries in a total of 42 lesions. 13) However, a sys tematic study of regional cerebral perfusion prior to and after PTA in the posterior circulation has not been reported.321 PTA was performed in 43 patients aged between 45 and 86 years (mean ± SD 65.8 ± 8.0 years) for clinically symptomatic atherosclerotic stenotic le sions involving the extra and/or intracranial ver tebrobasilar arterial system between December 1992 and October 1994. The degree of stenosis was more than 70% in all patients. Patients with vertebrobasi lar insufficiency and less than 70% stenosis were ex cluded. The 43 patients had no other stenotic lesions in the cerebral arteries. A total of 51 stenotic lesions were treated, including 17 in the first segment of the vertebral artery, 32 in the fourth segment of the ver tebral artery, and two in the basilar artery. All patients with ischemic symptoms in the posterior cir culation had definitive ischemia according to the rigid criteria of Cartlidge et a].4) No patient had ischemic symptoms or stenosis/occlusion in the terri tories of the internal carotid arteries. The ver tebrobasilar arterial systems were not completely isolated from the carotid territory circulation. Com puted tomography (CT) and/or magnetic resonance (MR) imaging showed small brain stem infarction and cerebellar infarction in 36 and 17 of the 43 patients, respectively.
All 43 patients had completed stroke and/or tran sient ischemic attacks (TIAs) and their neurological symptoms transiently and intermittently fluctuated and worsened despite various treatments, including hypervolemia, anticoagulation, and/or antiplatelet aggregation therapy. Data acquisition in the resting state was begun 5 minutes after injection of 370 MBq of 99mTc-HMPAO with a three-head rotating gamma camera. The thick ness of the transaxial slices was 10 mm. After com pletion of data acquisition (128 X 128 acquisition matrix) in the baseline examination (prior to the administration of acetazolamide), 10 mg/kg of acetazolamide was injected intravenously. 16,17,27,31,37) Fifteen minutes later, 555 MBq of 99mTc-HMPAO was injected, and data acquisition was restarted 5 minutes after this second injection. The acquired data yielded combined pre-/post-acetazolamide ac quisition values. Decay-corrected subtraction of the pre-acetazolamide acquisition value of radioisotope count from the combined pre-/post-acetazolamide ac quisition value yielded post-acetazolamide value for each pixel. Pre and post-acetazolamide tomograph ic images were obtained following reconstruction us ing the pre and post-acetazolamide acquisition values. Regions of interest (ROIs) were selected on the cerebral perfusion map obtained by 99mTc HMPAO SPECT prior to and after administration of acetazolamide in the territory of the cerebellum (ROI-1) and bilaterally in the territory of the middle cerebral arteries (ROIs-2 and 3) (Fig. 1) . Selection of these ROIs was standardized from case to case. Fig. 1 Regions of interest selected in the territory of the cerebellum (1) and bilaterally in the territory of the middle cerebral arteries (2 and 3).
Percentage regional perfusion in the posterior cir culation was defined as mean uptake per pixel in ROI-1/(mean uptake per pixel in ROI-2 + ROI-3) X 100. The change in regional perfusion following ad ministration of acetazolamide was defined as vasodilatory response calculated as (regional perfu sion after acetazolamide regional perfusion prior to acetazolamide)/regional perfusion prior to acetazolamide X 100.
Cerebral perfusion studies were conducted before and more than 7 months after PTA. The regional per fusion and vasodilatory response before PTA and more than 7 months after PTA were compared.
III. Intravascular technique
A 7-Fr coaxial guiding catheter (GCA 7/5; Nycomed Ingenor, Paris, France) was positioned in the vertebral artery or the subclavian artery via the transfemoral route. PTA was performed using a Stealth dilation balloon catheter (Target Therapeu tics, Fremont, Calif., U.S.A.). The balloon diameter was determined by measuring the normal caliber of the vessels both above and below the site of stenosis. The diameter of the balloon chosen approximated but did not exceed the normal luminal diameter, since overdilation sometimes induces vascular dis section. The microballoon catheters used were be tween 2 and 3.5 mm in diameter (in 0.5-mm incre ments). The Stealth dilation balloon catheter was introduced into the lesions through the guiding catheter following intravenous administration of 3000 IU of heparin. The balloon was inflated up to the maximum recommended balloon pressure of 3 to 7 atm. for less than 60 seconds using a gauged infla tor (Indeflator Plus 20TM; Advanced Cardiovascular Systems, Inc., Temecula, Calif., U.S.A. Patients were followed up by clinical examination, and angiography and cerebral perfusion studies to assess the results of therapy more than 7 months af ter PTA, because restenosis usually occurs within 3 to 5 months after PTA and no further stenosis oc curred on lesions free from 3 to 5-month resteno sis.19,40) The relationship between clinical improve ment after PTA and change in hemodynamic condition measured by 99mTc-HMPAO SPECT was evaluated. The follow-up period ranged from 7 to 19 months (mean 13.4 ± 3.0 months). Control values of regional perfusion and vasodilatory response were obtained in 14 patients with Meniere's disease be tween 42 and 78 years of age (62.1 ± 9.1 years). Values of hemodynamic parameters less than the control value 2 SDs were defined as subnormal. The degree of stenosis was 81.3 ± 7.4% before PTA, significantly less at 31.6 ± 12.1% just after PTA, and then slightly increased at 41.5 ± 17.4% at follow-up. Restenosis occurred in 24 of the 51 le sions at follow-up. Restenosis was detected in 11 of 17 lesions of the first segment of the vertebral artery, and 12 of 32 lesions of the fourth segment of the ver tebral artery.
However, there was no significant difference (p = 0.069). Restenosis was found in one of two lesions of the basilar artery. The degree of the restenosis was mild except in Cases 9, 12, 27, and 43 . These four patients had severe restenosis of 90%, 70%, 70%, and 90%, respectively.
Cases 9 and 43 were retreated by PTA and the stenosis improved to 50% and 25%, respectively.
These four patients were also medically treated by antiplatelet therapy , but showed no improvement. II Regional perfusion and vasodilatory response prior to PTA in the 24 patients who showed clinical improvement after PTA were 96.2 ± 11.7% and 3.93 ± 2.82%, respectively, both significantly low er than the control values (unpaired t-test, p < 0.0001). Regional perfusion and vasodilatory response in these 24 patients after PTA were 114.3 ± 7.7% and 0.94 ± 1.59%, respectively, with the lat ter significantly lower than the control value (un paired t-test, p < 0.0001). Both regional perfusion and vasodilatory response were significantly im proved after PTA (paired t-test, p < 0.01 and p < 0.01, respectively). Regional perfusion and vasodila tory response prior to PTA in the 19 patients who did not show clinical improvement were 114.2 --' 7.6% and 1.74 ± 2.77%, respectively, with no sig nificant difference compared with the control values. There was no significant difference in regional perfusion or vasodilatory response before and after PTA (paired t-test). Regional perfusion and vasodilatory response before PTA in the 24 patients were both significantly lower than in the 19 patients (unpaired t-test, p < 0.0001 and p < 0.01, respec tively).
IV. Complications
TIAs or strokes occurred as complications of the procedure in only Case 43. Three patients (Cases 13, 23, and 42) suffered transient asymptomatic arterial dissection just after PTA, which was not present at the follow-up. Case 43 with diffuse basilar artery ste nosis suffered pontine infarction after PTA and sub sequent neurological deterioration, but her neurolog ical condition improved to that before PTA after 1 month.
Illustrative Case
A 58-year-old male (Case 25) was admitted on June 3, 1993 with repetitive TIAs manifesting as quadripare sis, dysarthria, and/or loss of consciousness, begin ning in April 1993. He had received oral administra tion of 330 mg of aspirin per day, but the TIAs continued to occur frequently. MR imaging on ad mission disclosed cerebellar and pontine infarction (Fig. 2) . Cerebral angiography performed on June 4, 1993 disclosed 80% stenosis of the first segment of the right vertebral artery and 95% stenosis of the fourth segment of the left vertebral artery (Fig. 3 left) . The right vertebral artery was hypoplastic. 99mTc HMPAO SPECT cerebral perfusion study disclosed a region of low perfusion (80.3%) in the posterior cir culation (Fig. 4 upper left) . Vasodilatory response af ter administration of acetazolamide in the posterior circulation was markedly reduced ( 7.19%) (Fig. 4  lower left) . On June 6, PTA with a 2.5 x 10 mm Stealth catheter was performed on the first segment of the right vertebral artery, with dilation of the stenotic lesion to only 30% stenosis. Second PTA was performed on the stenotic lesion of the fourth segment of the left vertebral artery on June 13, 1993. The Stealth catheter used for the second PTA was 3.0 X 10 mm. Marked dilation of the stenotic lesion was achieved (Fig. 3 center) . Postoperatively, com plete remission of the TIAs was obtained with 330 mg of aspirin per day. The patient was discharged on June 20, 1993.
Follow-up angiography performed on September 12, 1994 demonstrated maintenance of dilation and no evidence of restenosis (Fig. 3 right) . 99mTc HMPAO SPECT cerebral perfusion study per formed on the same day disclosed an increase in cerebral perfusion (110.2%) in the posterior circula tion (Fig. 4 upper right) and increased vasodilatory response (2.41%) compared with that prior to PTA (Fig. 4 lower right) . tem. Twelve patients with a unilateral stenotic lesion in the extracranial vertebral artery (the first segment of the vertebral artery) had neither subnor mal perfusion nor subnormal vasodilatory response, and only one of these patients showed clinical im provement after PTA. This patient (Case 5) suffered from reversible ischemic neurological deficits and TIAs associated with left Wallenberg's syndrome. Cerebral angiography showed that the left vertebral artery was severely stenotic in its first segment, end ed in the posterior inferior cerebellar artery, and received no collaterals from the contralateral ver tebral artery. 99mTc-HMPAO SPECT showed that cerebral perfusion and hemodynamic reserve in the left cerebellar hemisphere were below normal prior to PTA, but were significantly increased after PTA. These findings suggest that patients with a single ste nosis of the first segment of the vertebral artery and normal regional perfusion and vasodilatory response have marked development of collaterals to a distal portion of the stenosis via the contralateral vertebral artery (and/or various extracranial vessels).") Repetitive and/or unstable ischemia in those patients may be due to intraarterial emboliza tion and/or small vessel disease. In contrast, many of the 31 patients with intracranial lesions or multiple stenotic lesions had subnormal perfusion (22 pa tients) and subnormal vasodilatory response (23 pa tients), respectively. 
